img

Global Vaginal Fungi Infections Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vaginal Fungi Infections Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Vaginal candidiasis is usually treated with antifungal medicine. For most infections, the treatment is an antifungal medicine applied inside the vagina or a single dose of fluconazole taken by mouth.
Vaginal Fungi Infections Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vaginal Fungi Infections Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vaginal Fungi Infections Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Vaginal Fungi Infections Treatment key companies include Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals and PEPTONIC medical AB, etc. Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals are top 3 players and held % share in total in 2022.
Vaginal Fungi Infections Treatment can be divided into Fluconazole, Nystatin, Flucytosine and Others, etc. Fluconazole is the mainstream product in the market, accounting for % share globally in 2022.
Vaginal Fungi Infections Treatment is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Vaginal Fungi Infections Treatment industry development. In 2022, global % share of Vaginal Fungi Infections Treatment went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaginal Fungi Infections Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer Inc.
Bausch Health Companies Inc
ANI Pharmaceuticals
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS
Segment by Type
Fluconazole
Nystatin
Flucytosine
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vaginal Fungi Infections Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Vaginal Fungi Infections Treatment introduction, etc. Vaginal Fungi Infections Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Vaginal Fungi Infections Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Vaginal Fungi Infections Treatment
1.1 Vaginal Fungi Infections Treatment Market Overview
1.1.1 Vaginal Fungi Infections Treatment Product Scope
1.1.2 Vaginal Fungi Infections Treatment Market Status and Outlook
1.2 Global Vaginal Fungi Infections Treatment Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Vaginal Fungi Infections Treatment Market Size by Region (2024-2034)
1.4 Global Vaginal Fungi Infections Treatment Historic Market Size by Region (2024-2024)
1.5 Global Vaginal Fungi Infections Treatment Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Vaginal Fungi Infections Treatment Market Size (2024-2034)
1.6.1 North America Vaginal Fungi Infections Treatment Market Size (2024-2034)
1.6.2 Europe Vaginal Fungi Infections Treatment Market Size (2024-2034)
1.6.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size (2024-2034)
1.6.4 Latin America Vaginal Fungi Infections Treatment Market Size (2024-2034)
1.6.5 Middle East & Africa Vaginal Fungi Infections Treatment Market Size (2024-2034)
2 Vaginal Fungi Infections Treatment Market by Type
2.1 Introduction
2.1.1 Fluconazole
2.1.2 Nystatin
2.1.3 Flucytosine
2.1.4 Others
2.2 Global Vaginal Fungi Infections Treatment Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Vaginal Fungi Infections Treatment Historic Market Size by Type (2024-2024)
2.2.2 Global Vaginal Fungi Infections Treatment Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Vaginal Fungi Infections Treatment Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Vaginal Fungi Infections Treatment Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Vaginal Fungi Infections Treatment Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Vaginal Fungi Infections Treatment Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Vaginal Fungi Infections Treatment Revenue Breakdown by Type (2024-2034)
3 Vaginal Fungi Infections Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Vaginal Fungi Infections Treatment Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Vaginal Fungi Infections Treatment Historic Market Size by Application (2024-2024)
3.2.2 Global Vaginal Fungi Infections Treatment Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Vaginal Fungi Infections Treatment Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Vaginal Fungi Infections Treatment Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Vaginal Fungi Infections Treatment Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Vaginal Fungi Infections Treatment Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Vaginal Fungi Infections Treatment Revenue Breakdown by Application (2024-2034)
4 Vaginal Fungi Infections Treatment Competition Analysis by Players
4.1 Global Vaginal Fungi Infections Treatment Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaginal Fungi Infections Treatment as of 2022)
4.3 Date of Key Players Enter into Vaginal Fungi Infections Treatment Market
4.4 Global Top Players Vaginal Fungi Infections Treatment Headquarters and Area Served
4.5 Key Players Vaginal Fungi Infections Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Vaginal Fungi Infections Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer Inc.
5.1.1 Pfizer Inc. Profile
5.1.2 Pfizer Inc. Main Business
5.1.3 Pfizer Inc. Vaginal Fungi Infections Treatment Products, Services and Solutions
5.1.4 Pfizer Inc. Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.1.5 Pfizer Inc. Recent Developments
5.2 Bausch Health Companies Inc
5.2.1 Bausch Health Companies Inc Profile
5.2.2 Bausch Health Companies Inc Main Business
5.2.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Products, Services and Solutions
5.2.4 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.2.5 Bausch Health Companies Inc Recent Developments
5.3 ANI Pharmaceuticals
5.3.1 ANI Pharmaceuticals Profile
5.3.2 ANI Pharmaceuticals Main Business
5.3.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Products, Services and Solutions
5.3.4 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.3.5 Hikma Pharmaceuticals Plc Recent Developments
5.4 Hikma Pharmaceuticals Plc
5.4.1 Hikma Pharmaceuticals Plc Profile
5.4.2 Hikma Pharmaceuticals Plc Main Business
5.4.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Products, Services and Solutions
5.4.4 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.4.5 Hikma Pharmaceuticals Plc Recent Developments
5.5 Lupin Limited
5.5.1 Lupin Limited Profile
5.5.2 Lupin Limited Main Business
5.5.3 Lupin Limited Vaginal Fungi Infections Treatment Products, Services and Solutions
5.5.4 Lupin Limited Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.5.5 Lupin Limited Recent Developments
5.6 Mycovia Pharmaceuticals
5.6.1 Mycovia Pharmaceuticals Profile
5.6.2 Mycovia Pharmaceuticals Main Business
5.6.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Products, Services and Solutions
5.6.4 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.6.5 Mycovia Pharmaceuticals Recent Developments
5.7 Glenmark Pharmaceuticals Limited
5.7.1 Glenmark Pharmaceuticals Limited Profile
5.7.2 Glenmark Pharmaceuticals Limited Main Business
5.7.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Products, Services and Solutions
5.7.4 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.7.5 Glenmark Pharmaceuticals Limited Recent Developments
5.8 Unique Pharmaceuticals
5.8.1 Unique Pharmaceuticals Profile
5.8.2 Unique Pharmaceuticals Main Business
5.8.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Products, Services and Solutions
5.8.4 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.8.5 Unique Pharmaceuticals Recent Developments
5.9 PEPTONIC medical AB
5.9.1 PEPTONIC medical AB Profile
5.9.2 PEPTONIC medical AB Main Business
5.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Products, Services and Solutions
5.9.4 PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.9.5 PEPTONIC medical AB Recent Developments
5.10 Aurobindo Pharma Limited
5.10.1 Aurobindo Pharma Limited Profile
5.10.2 Aurobindo Pharma Limited Main Business
5.10.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Products, Services and Solutions
5.10.4 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.10.5 Aurobindo Pharma Limited Recent Developments
5.11 Dr. Reddy's Laboratories
5.11.1 Dr. Reddy's Laboratories Profile
5.11.2 Dr. Reddy's Laboratories Main Business
5.11.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Products, Services and Solutions
5.11.4 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.11.5 Dr. Reddy's Laboratories Recent Developments
5.12 SCYNEXIS
5.12.1 SCYNEXIS Profile
5.12.2 SCYNEXIS Main Business
5.12.3 SCYNEXIS Vaginal Fungi Infections Treatment Products, Services and Solutions
5.12.4 SCYNEXIS Vaginal Fungi Infections Treatment Revenue (US$ Million) & (2024-2024)
5.12.5 SCYNEXIS Recent Developments
6 North America
6.1 North America Vaginal Fungi Infections Treatment Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Vaginal Fungi Infections Treatment Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Vaginal Fungi Infections Treatment Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Vaginal Fungi Infections Treatment Market Dynamics
11.1 Vaginal Fungi Infections Treatment Industry Trends
11.2 Vaginal Fungi Infections Treatment Market Drivers
11.3 Vaginal Fungi Infections Treatment Market Challenges
11.4 Vaginal Fungi Infections Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Vaginal Fungi Infections Treatment Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Vaginal Fungi Infections Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Vaginal Fungi Infections Treatment Market Size Share by Region (2024-2024)
Table 4. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Vaginal Fungi Infections Treatment Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Vaginal Fungi Infections Treatment Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Vaginal Fungi Infections Treatment Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2024-2024)
Table 9. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2024-2034)
Table 11. North America Vaginal Fungi Infections Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Vaginal Fungi Infections Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Vaginal Fungi Infections Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Vaginal Fungi Infections Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Vaginal Fungi Infections Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Vaginal Fungi Infections Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Vaginal Fungi Infections Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Vaginal Fungi Infections Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Vaginal Fungi Infections Treatment Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Vaginal Fungi Infections Treatment Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2024-2024)
Table 24. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2024-2034)
Table 26. North America Vaginal Fungi Infections Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Vaginal Fungi Infections Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Vaginal Fungi Infections Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Vaginal Fungi Infections Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Vaginal Fungi Infections Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Vaginal Fungi Infections Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Vaginal Fungi Infections Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Vaginal Fungi Infections Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Vaginal Fungi Infections Treatment Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Vaginal Fungi Infections Treatment Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaginal Fungi Infections Treatment as of 2022)
Table 39. Date of Key Players Enter into Vaginal Fungi Infections Treatment Market
Table 40. Global Vaginal Fungi Infections Treatment Key Players Headquarters and Area Served
Table 41. Vaginal Fungi Infections Treatment Product Solution and Service
Table 42. Global Vaginal Fungi Infections Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Inc. Basic Information List
Table 45. Pfizer Inc. Description and Business Overview
Table 46. Pfizer Inc. Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Pfizer Inc. (2024-2024)
Table 48. Pfizer Inc. Recent Developments
Table 49. Bausch Health Companies Inc Basic Information List
Table 50. Bausch Health Companies Inc Description and Business Overview
Table 51. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Bausch Health Companies Inc (2024-2024)
Table 53. Bausch Health Companies Inc Recent Developments
Table 54. ANI Pharmaceuticals Basic Information List
Table 55. ANI Pharmaceuticals Description and Business Overview
Table 56. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of ANI Pharmaceuticals (2024-2024)
Table 58. ANI Pharmaceuticals Recent Developments
Table 59. Hikma Pharmaceuticals Plc Basic Information List
Table 60. Hikma Pharmaceuticals Plc Description and Business Overview
Table 61. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Hikma Pharmaceuticals Plc (2024-2024)
Table 63. Hikma Pharmaceuticals Plc Recent Developments
Table 64. Lupin Limited Basic Information List
Table 65. Lupin Limited Description and Business Overview
Table 66. Lupin Limited Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Lupin Limited (2024-2024)
Table 68. Lupin Limited Recent Developments
Table 69. Mycovia Pharmaceuticals Basic Information List
Table 70. Mycovia Pharmaceuticals Description and Business Overview
Table 71. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Mycovia Pharmaceuticals (2024-2024)
Table 73. Mycovia Pharmaceuticals Recent Developments
Table 74. Glenmark Pharmaceuticals Limited Basic Information List
Table 75. Glenmark Pharmaceuticals Limited Description and Business Overview
Table 76. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Glenmark Pharmaceuticals Limited (2024-2024)
Table 78. Glenmark Pharmaceuticals Limited Recent Developments
Table 79. Unique Pharmaceuticals Basic Information List
Table 80. Unique Pharmaceuticals Description and Business Overview
Table 81. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Unique Pharmaceuticals (2024-2024)
Table 83. Unique Pharmaceuticals Recent Developments
Table 84. PEPTONIC medical AB Basic Information List
Table 85. PEPTONIC medical AB Description and Business Overview
Table 86. PEPTONIC medical AB Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of PEPTONIC medical AB (2024-2024)
Table 88. PEPTONIC medical AB Recent Developments
Table 89. Aurobindo Pharma Limited Basic Information List
Table 90. Aurobindo Pharma Limited Description and Business Overview
Table 91. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 92. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Aurobindo Pharma Limited (2024-2024)
Table 93. Aurobindo Pharma Limited Recent Developments
Table 94. Dr. Reddy's Laboratories Basic Information List
Table 95. Dr. Reddy's Laboratories Description and Business Overview
Table 96. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 97. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of Dr. Reddy's Laboratories (2024-2024)
Table 98. Dr. Reddy's Laboratories Recent Developments
Table 99. SCYNEXIS Basic Information List
Table 100. SCYNEXIS Description and Business Overview
Table 101. SCYNEXIS Vaginal Fungi Infections Treatment Products, Services and Solutions
Table 102. Revenue (US$ Million) in Vaginal Fungi Infections Treatment Business of SCYNEXIS (2024-2024)
Table 103. SCYNEXIS Recent Developments
Table 104. North America Vaginal Fungi Infections Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 105. North America Vaginal Fungi Infections Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 106. Europe Vaginal Fungi Infections Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 107. Europe Vaginal Fungi Infections Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 108. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 109. Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 110. Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 111. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Region (2024-2024)
Table 112. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Region (2024-2034)
Table 113. Latin America Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 114. Latin America Vaginal Fungi Infections Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 115. Latin America Vaginal Fungi Infections Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 116. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 117. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 118. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 119. Vaginal Fungi Infections Treatment Market Trends
Table 120. Vaginal Fungi Infections Treatment Market Drivers
Table 121. Vaginal Fungi Infections Treatment Market Challenges
Table 122. Vaginal Fungi Infections Treatment Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaginal Fungi Infections Treatment Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Vaginal Fungi Infections Treatment Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Vaginal Fungi Infections Treatment Market Share by Regions: 2022 VS 2034
Figure 4. Global Vaginal Fungi Infections Treatment Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Vaginal Fungi Infections Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Vaginal Fungi Infections Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Vaginal Fungi Infections Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Fluconazole
Figure 11. Global Fluconazole Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Nystatin
Figure 13. Global Nystatin Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Flucytosine
Figure 15. Global Flucytosine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Vaginal Fungi Infections Treatment Market Size Share by Type: 2022 & 2034
Figure 19. North America Vaginal Fungi Infections Treatment Revenue Market Share by Type (2024-2034)
Figure 20. Europe Vaginal Fungi Infections Treatment Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Vaginal Fungi Infections Treatment Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Vaginal Fungi Infections Treatment Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Vaginal Fungi Infections Treatment Revenue Market Share by Type (2024-2034)
Figure 24. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Online Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Global Vaginal Fungi Infections Treatment Market Size Share by Application: 2022 & 2034
Figure 28. North America Vaginal Fungi Infections Treatment Revenue Market Share by Application (2024-2034)
Figure 29. Europe Vaginal Fungi Infections Treatment Revenue Market Share by Application (2024-2034)
Figure 30. Asia-Pacific Vaginal Fungi Infections Treatment Revenue Market Share by Application (2024-2034)
Figure 31. Latin America Vaginal Fungi Infections Treatment Revenue Market Share by Application (2024-2034)
Figure 32. Middle East and Africa Vaginal Fungi Infections Treatment Revenue Market Share by Application (2024-2034)
Figure 33. Vaginal Fungi Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 34. Global Top 5 and Top 10 Players Vaginal Fungi Infections Treatment Market Share in 2022
Figure 35. North America Vaginal Fungi Infections Treatment Market Share by Country (2024-2034)
Figure 36. United States Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 37. Canada Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 38. Germany Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 39. France Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 40. U.K. Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 41. Italy Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 42. Russia Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 43. Nordic Countries Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 44. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Region (2024-2034)
Figure 45. China Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 46. Japan Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 47. South Korea Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 48. Southeast Asia Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 49. India Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 50. Australia Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 51. Latin America Vaginal Fungi Infections Treatment Market Share by Country (2024-2034)
Figure 52. Mexico Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 53. Brazil Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 54. Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Country (2024-2034)
Figure 55. Turkey Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 56. Saudi Arabia Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 57. UAE Vaginal Fungi Infections Treatment Market Size (2024-2034) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries